DDRGK1 Enhances Osteosarcoma Chemoresistance via Inhibiting KEAP1‐Mediated NRF2 Ubiquitination

DDRGK1 Enhances Osteosarcoma Chemoresistance via Inhibiting KEAP1‐Mediated NRF2 Ubiquitination

Abstract Chemoresistance is the main obstacle in osteosarcoma (OS) treatment; however, the underlying mechanism remains unclear. In this study, it is discovered that DDRGK domain‐containing protein 1 (DDRGK1) plays a fundamental role in chemoresistance induced in OS. Bioinformatic and tissue analyse...

Full description

Bibliographic Details
Main Authors: Xin Wang, Tangjun Zhou, Xiao Yang, Xiankun Cao, Gu Jin, Pu Zhang, Jiadong Guo, Kewei Rong, Baixing Li, Yibin Hu, Kexin Liu, Peixiang Ma, An Qin, Jie Zhao
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:Advanced Science
Subjects:
chemoresistance
DDRGK domain‐containing protein 1
doxorubicin
osteosarcoma
redox homeostasis
Online Access:https://doi.org/10.1002/advs.202204438

Internet

https://doi.org/10.1002/advs.202204438

Similar Items